Goodrx Holdings Inc
NASDAQ:GDRX
Goodrx Holdings Inc
Accounts Receivables
Goodrx Holdings Inc
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Accounts Receivables
$143.6m
|
CAGR 3-Years
28%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
NYSE:VEEV
|
Accounts Receivables
$888.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
23%
|
CAGR 10-Years
31%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Accounts Receivables
$72.3m
|
CAGR 3-Years
50%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Accounts Receivables
$427.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Accounts Receivables
$112m
|
CAGR 3-Years
62%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Certara Inc
NASDAQ:CERT
|
Accounts Receivables
$84.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
See Also
What is Goodrx Holdings Inc's Accounts Receivables?
Accounts Receivables
143.6m
USD
Based on the financial report for Dec 31, 2023, Goodrx Holdings Inc's Accounts Receivables amounts to 143.6m USD.
What is Goodrx Holdings Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
34%
Over the last year, the Accounts Receivables growth was 23%. The average annual Accounts Receivables growth rates for Goodrx Holdings Inc have been 28% over the past three years , 34% over the past five years .